Rik Ossenkoppele

Overview

Best Publications

• Brain charts for the human lifespan

  Unknown

  2075
  Citations

• Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

  Willemijn J. Jansen;Rik Ossenkoppele;Dirk L. Knol;Betty M. Tijms

  1712
  Citations

• Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance

  Yaakov Stern;Eider M. Arenaza-Urquijo;David Bartrés-Faz;Sylvie Belleville

  1529
  Citations

• PET Imaging of Tau Deposition in the Aging Human Brain

  Michael Schöll;Michael Schöll;Samuel N. Lockhart;Daniel R. Schonhaut;James P. O’Neil

  1286
  Citations

• Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

  Rik Ossenkoppele;Rik Ossenkoppele;Rik Ossenkoppele;Daniel R. Schonhaut;Daniel R. Schonhaut;Michael Schöll;Michael Schöll;Samuel N. Lockhart

  1221
  Citations

• The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials

  C. Groot;A.M. Hooghiemstra;P.G.H.M. Raijmakers;B.N.M. van Berckel

  735
  Citations

• Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.

  Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol

  710
  Citations

• Four distinct trajectories of tau deposition identified in Alzheimer’s disease

  Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

  683
  Citations

• The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

  Rik Ossenkoppele;Yolande A. L. Pijnenburg;David C. Perry;Brendan I. Cohn-Sheehy

  573
  Citations

• Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials

  Unknown

  564
  Citations

• Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

  Unknown

  536
  Citations

• Amyloid-β-independent regulators of tau pathology in Alzheimer disease.

  Rik van der Kant;Lawrence S.B. Goldstein;Rik Ossenkoppele;Rik Ossenkoppele

  533
  Citations

• Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

  Jacob W. Vogel;Yasser Iturria-Medina;Olof T. Strandberg;Ruben Smith

  522
  Citations

• Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

  Gaël Chételat;Javier Arbizu;Henryk Barthel;Valentina Garibotto

  498
  Citations

• The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.

  Giovanni B Frisoni;Giovanni B Frisoni;Daniele Altomare;Daniele Altomare;Dietmar Rudolf Thal;Federica Ribaldi

  470
  Citations

• Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders

  Rik Ossenkoppele;Rik Ossenkoppele;Gil D. Rabinovici;Ruben Smith;Hanna Cho

  468
  Citations

• Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

  Unknown

  418
  Citations

• Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease.

  Niklas Mattsson-Carlgren;Emelie Andersson;Shorena Janelidze;Rik Ossenkoppele;Rik Ossenkoppele

  339
  Citations

• Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.

  Rik Ossenkoppele;Ruben Smith;Tomas Ohlsson;Olof Strandberg

  309
  Citations

• Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.

  Rik Ossenkoppele;Rik Ossenkoppele;Ruben Smith;Niklas Mattsson-Carlgren;Colin Groot

  290
  Citations

• Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.

  David Berron;Danielle van Westen;Rik Ossenkoppele;Rik Ossenkoppele;Olof Strandberg

  279
  Citations

• Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease

  Rik Ossenkoppele;Brendan I. Cohn-Sheehy;Renaud La Joie;Jacob W. Vogel

  249
  Citations

• Impact of molecular imaging on the diagnostic process in a memory clinic

  Rik Ossenkoppele;Niels D. Prins;Yolande A.L. Pijnenburg;Afina W. Lemstra

  219
  Citations

• Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

  Annapaola Prestia;Anna Caroli;Wiesje M. van der Flier;Rik Ossenkoppele

  216
  Citations